Annual Drug Patent Expirations for QINLOCK
Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are seven patents protecting this drug.
This drug has forty-six patent family members in twelve countries.
The generic ingredient in QINLOCK is ripretinib. Additional details are available on the ripretinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
